|View printer-friendly version|
|Vitae Pharmaceuticals Announces Pricing of Initial Public Offering|
A registration statement relating to these securities has been filed with, and declared effective by, the
The offering is being made only by means of a written prospectus forming part of the effective registration statement. Copies of the prospectus related to the offering may be obtained from
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.